Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.

Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ.

Drug Alcohol Depend. 2013 Mar 1;128(3):206-13. doi: 10.1016/j.drugalcdep.2012.08.025. Epub 2012 Sep 16.

2.

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.

Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR.

Psychopharmacology (Berl). 2012 Sep;223(1):1-15. doi: 10.1007/s00213-012-2680-6. Epub 2012 Apr 13. Erratum in: Psychopharmacology (Berl). 2013 Aug;228(3):513.

3.

Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers.

Carter LP, Kleykamp BA, Griffiths RR, Mintzer MZ.

Psychopharmacology (Berl). 2013 Mar;226(1):53-63. doi: 10.1007/s00213-012-2883-x. Epub 2012 Oct 25.

4.

Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.

Johnson MW, Suess PE, Griffiths RR.

Arch Gen Psychiatry. 2006 Oct;63(10):1149-57.

PMID:
17015817
5.

Triazolam and zolpidem: effects on human memory and attentional processes.

Mintzer MZ, Griffiths RR.

Psychopharmacology (Berl). 1999 May;144(1):8-19.

PMID:
10379619
6.

Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers.

Carter LP, Griffiths RR, Mintzer MZ.

Psychopharmacology (Berl). 2009 Sep;206(1):141-54. doi: 10.1007/s00213-009-1589-1. Epub 2009 Jun 20.

7.

Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers.

Kleykamp BA, Griffiths RR, Mintzer MZ.

Exp Clin Psychopharmacol. 2010 Feb;18(1):1-16. doi: 10.1037/a0018407.

8.

The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.

Miyata A, Iwamoto K, Kawano N, Kohmura K, Yamamoto M, Aleksic B, Ebe K, Noda A, Noda Y, Iritani S, Ozaki N.

Psychopharmacology (Berl). 2015 Jun;232(12):2127-37. doi: 10.1007/s00213-014-3843-4. Epub 2014 Dec 24.

PMID:
25533998
9.

Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB.

Carter LP, Richards BD, Mintzer MZ, Griffiths RR.

Neuropsychopharmacology. 2006 Nov;31(11):2537-51. Epub 2006 Jul 26.

10.

Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.

Carter LP, Griffiths RR, Suess PE, Casada JH, Wallace CL, Roache JD.

J Pharmacol Exp Ther. 2007 Aug;322(2):749-59. Epub 2007 May 14.

11.

Psychophysiological effects and dose equivalence of zopiclone and triazolam administered to healthy volunteers. Methodological considerations.

Gorenstein C, Tavares SM, Gentil V, Peres C, Moreno RA, Dreyfus JF.

Braz J Med Biol Res. 1990;23(10):941-51.

PMID:
2101059
12.

A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal.

Mintzer MZ, Griffiths RR.

Psychopharmacology (Berl). 2007 Jun;192(3):425-40. Epub 2007 Mar 7.

PMID:
17342474
13.

Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.

Rush CR, Baker RW, Wright K.

Psychopharmacology (Berl). 1999 Jun;144(3):220-33.

PMID:
10435388
14.

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.

Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR.

Psychopharmacology (Berl). 2018 Feb;235(2):521-534. doi: 10.1007/s00213-017-4769-4. Epub 2017 Nov 7.

PMID:
29116367
15.

Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.

Mintzer MZ, Frey JM, Yingling JE, Griffiths RR.

Behav Pharmacol. 1997 Nov;8(6-7):561-74.

PMID:
9832970
16.

Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.

Hallam KT, Olver JS, McGrath C, Norman TR.

Hum Psychopharmacol. 2003 Dec;18(8):619-25.

PMID:
14696021
17.

Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.

Mintzer MZ, Griffiths RR.

Drug Alcohol Depend. 1998 Dec 1;53(1):49-66.

PMID:
10933340
18.

The Effects of Dextromethorphan on Driving Performance and the Standardized Field Sobriety Test.

Perry PJ, Fredriksen K, Chew S, Ip EJ, Lopes I, Doroudgar S, Thomas K.

J Forensic Sci. 2015 Sep;60(5):1258-62. doi: 10.1111/1556-4029.12833. Epub 2015 Aug 21.

PMID:
26294136
19.

Respiratory and sedative effects of triazolam in volunteers.

Longbottom RT, Pleuvry BJ.

Br J Anaesth. 1984 Feb;56(2):179-85.

20.

Side effects of triazolam in children.

Coldwell SE, Awamura K, Milgrom P, Depner KS, Kaufman E, Preston KL, Karl HW.

Pediatr Dent. 1999 Jan-Feb;21(1):18-25.

PMID:
10029963

Supplemental Content

Support Center